Interventional Spine's PerX360 System to be presented at ISASS annual meeting

NewsGuard 100/100 Score

Interventional Spine®, Inc. today announced that Dr. Rudolf Morgenstern, Director and Chief Surgeon of the Morgenstern Institute for Endoscopic Spine Surgery at Centro Medico Teknon in Barcelona, and Dr. David Greenwald from Flagler Brain and Spine Institute of St. Augustine, Florida will present the PerX360™ System at the International Society for the Advancement of Spine Surgery (ISASS) Annual Meeting in Barcelona, Spain. 

The PerX360 System is the first and only system in the world capable of providing surgeons the ability to perform a percutaneous interbody fusion via two incisions that are less than 15mm each for the treatment of lumbar discogenic pain.  Dr. Morgenstern was a major contributor to the design of the PerX360 System and an early adopter of the technology.  He implanted the first patient, soon after the system achieved CE certification in April of last year.  His presentation will include nine months of patient data and details of the surgical technique he developed.

Dr. Greenwald will be presenting his initial patient data from his first implant of the Opticage™ in the United States performed on March 8, 2012.

To date, 17 patients have benefitted from the PerX360 technology with excellent clinical results and significant drops in pain scores.

The presentation will take place at the Palau de Congressos de Catalunya on Wednesday, March 21, from 1:00pm to 2:30pm, in Rooms E4-6.  In addition, Interventional Spine will have booth #100 on the exhibit hall floor during the event.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Study provides evidence that antidepressant use in pregnancy affects child's brain development